Despite advancements in prenatal genetic screening, current medical technology cannot identify all genetic conditions in ...

Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...

Second Phase 3 Clinical ... in patients with cystic fibrosis ... Nov. 23, 2022 — Sometimes healthcare professionals treat patients with opioids such as morphine to relieve symptoms, but there ...

Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency: San Diego Wednesday, January 8, 2025, 13:00 Hrs [IST] Arcturus ...

A connection between lung health and kidney function in adults with cystic fibrosis (CF), identifying early urinary markers ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published ...

Viral and nonviral clinical trials have established proof-of-principle for gene transfer into the cystic fibrosis (CF) lung. It is currently unknown whether gene transfer efficiency is sufficient ...

Coughing is a natural reflex action that helps clear the airways of irritants, mucus, smoke, dust, or allergens. While most ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

CF affects every racial and ethnic group and is currently estimated to afflict more than 30,000 individuals in the United States and at least 100,000 people worldwide. 1,2,5 1. Shteinberg M, Haq IJ, ...